| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 02/26/2004 | CA2495956A1 Sulfonamides as potassium channel blockers |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390134A2 Bis (perfluoroalkanesulfonyl) imides and their salts as surfactants/additives for applications having extreme environments and methods therefor |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1206447B1 Selective inhibitors of the urokinase plasminogene activators |
| 02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1135369B1 Alpha-sulfin- and alpha-sulfonamino acid amides |
| 02/25/2004 | EP1135368B1 Alpha-sulfin- and alpha-sulfon-amino acid amides |
| 02/25/2004 | EP0883405B1 Amidino protease inhibitors |
| 02/25/2004 | EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696475 Substituted phenyl derivatives, their preparation and use |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014843A1 Substituted amino compounds and use thereof |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034072 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/19/2004 | US20040034070 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/19/2004 | US20040034011 Administering to a mammal a napthalene derivative containing at least two hydroxy groups at ortho position to one another, for the treatment of disorders caused by catechol-O-methyltransferase enzyme |
| 02/19/2004 | US20040033988 Sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation |
| 02/19/2004 | US20040033366 Bis(perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods therefor |
| 02/19/2004 | CA2495067A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 02/18/2004 | EP1389183A1 Sulfonamide derivatives |
| 02/18/2004 | EP1292572B1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | CN1476427A Phenoxyphenyl alkane sulfonates |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1475482A Chemical synthesis method of aryl sulfuryl isocyanate |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693137 Sulphonamide derivatives |
| 02/17/2004 | US6693136 Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2004013077A2 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | WO2003101381A3 1,2 diamido cycloalkyl sodium channel blockers |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040029945 Method of inhibiting matrix metalloproteinases |
| 02/12/2004 | US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | US20040026666 Imidazolium salts and their use of these ionic liquids as a solvent |
| 02/12/2004 | CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/11/2004 | EP1388546A2 Use of ionic compounds having a delocalised anionic charge as catalyst components |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1137878C Aryloxyaniline derivatives |
| 02/10/2004 | US6689896 Thyromimetic organic compounds |
| 02/10/2004 | CA2231026C Novel derivatives of benzenesulfonylamine, process for their preparation and pharmaceutical compositions containing them |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
| 02/05/2004 | US20040023938 The present invention relates to microbicides for agricultural or horticultural use containing sulfonamide derivative of, for example, a formula (I): or a salt thereof, (wherein A1 is (1) an aryl group which may be substituted or |
| 02/05/2004 | US20040023348 Microbiological process for enantioselective (S)-hydroxylation |
| 02/05/2004 | US20040023092 Exhibit extensive delocalization of the negative charge and good activity in polymerization or in copolymerization and allow the preparation of macromolecules possessing dissociated and stable ionic functional groups |
| 02/05/2004 | US20040021928 Electrolytes for electrooptic devices comprising ionic liquids |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/03/2004 | US6686395 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 01/29/2004 | WO2004009537A1 NOVEL α-KETOAMIDE DERIVATIVE AND USE THEREOF |
| 01/29/2004 | WO2003101948A3 Agents for imaging and diagnostic methods using them |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019042 Fluorenes and anthracenes that inhibit p2x3 and p2x2/3 containing receptors |
| 01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383741A2 Process for the preparation of benazepril |
| 01/28/2004 | EP1383488A2 Methods of synthesizing phenol-containing compounds |
| 01/28/2004 | EP0794947B1 N-substituted hydrazinophenylsulphonyl ureas used as herbicides and plant-growth regulators |
| 01/28/2004 | CN1471509A 9-substituted minocycline compounds |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/27/2004 | US6683209 Fuel cells, batteries, electrolytes |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |